Overview

Pharmacokinetics And Relative Bioavailability Study Of Oxycodone

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
To estimate the pharmacokinetics and relative bioavailability of oxycodone after administration of 40 mg doses of four PF-00345439 formulations and oxycodone in solution
Phase:
Phase 1
Details
Lead Sponsor:
Pain Therapeutics
Treatments:
Oxycodone